Themis Medicare is currently trading at Rs. 378.00, up by 18.00 points or 5.00% from its previous closing of Rs. 360.00 on the BSE.
The scrip opened at Rs. 372.00 and has touched a high and low of Rs. 378.00 and Rs. 372.00 respectively. So far 743 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 388.45 on 15-Jan-2020 and a 52 week low of Rs. 139.90 on 02-Aug-2019.
Last one week high and low of the scrip stood at Rs. 388.45 and Rs. 359.95 respectively. The current market cap of the company is Rs. 347.04 crore.
The promoters holding in the company stood at 67.32%, while Institutions and Non-Institutions held 0.01% and 32.67% respectively.
Themis Medicare is presently negotiating with various parties for utilising spare capacity for carrying out contract manufacturing of finished products, and if negotiations are successful, the company will enter into contracts with such parties.
Further, pursuant to notification issued by Ministry of Road Transport and Highways, Government of India, making it mandatory to include Feracrylum 1% Gel 15gms in first aid kit for all types of vehicles coming out from the Auto Manufacturers, the company has started receiving orders for supply of Feracrylum 1% Gel 15gms to be included in first aid kit and is likely to receive similar such orders in future.
Themis Medicare (TML) is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1677.10 |
| Dr. Reddys Lab | 1238.10 |
| Cipla | 1238.70 |
| Zydus Lifesciences | 942.95 |
| Lupin | 2327.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: